Effects of the transient receptor potential vanilloid 1 antagonist A-425619 on body temperature and thermoregulation in the rat

Neuroscience
C MillsM Bradbury

Abstract

Transient receptor potential vanilloid 1 (TRPV1) receptor antagonists have gained much attention for their potential to treat inflammatory and neuropathic pain. However, systemic administration of TRPV1 antagonists induces a period of hyperthermia, a potential liability for small molecule development. Here we characterize the effects of the TRPV1 antagonist A-425619 on body temperature (T(b)) in the rat when administered: (1) alone at different times of the circadian cycle, (2) as repeated hourly or daily treatment, (3) as pre-treatment to prevent capsaicin-induced hypothermia, (4) to capsaicin-desensitized animals, and (5) prior to a heat challenge. Changes in T(b) were compared with compound exposure data, locomotor activity, and time course of efficacy in inflammatory pain models. Without affecting locomotor activity, oral administration of A-425619 induced a transient period of hyperthermia that was followed by a period of hypothermia, a profile unique among reported TRPV1 antagonists. Repeated hourly administration of A-425619 produced an increase in T(b) similar to a single administration. A-425619 had no effect on T(b) when administered to capsaicin-desensitized rats. The duration of A-425619-induced hyperthermia, but no...Continue Reading

References

May 1, 1990·Physiology & Behavior·C J Gordon
Dec 1, 1984·Brain Research·L C Russell, K J Burchiel
Jan 1, 1984·Pharmacology & Therapeutics·T Hori
Aug 1, 1982·Naunyn-Schmiedeberg's Archives of Pharmacology·M SzikszayF Obál
Aug 5, 1998·The American Journal of Physiology·A KobayashiS Kimura
Feb 29, 2000·British Journal of Pharmacology·D SmartJ B Davis
Mar 31, 2000·Trends in Pharmacological Sciences·D Smart, J C Jerman
Sep 19, 2000·The Korean Journal of Internal Medicine·T H LeeS Kimura
Feb 9, 2002·Brain Research. Molecular Brain Research·Tamas SzaboPeter M Blumberg
Mar 16, 2004·The European Journal of Neuroscience·Z SzelényiJ B Davis
Oct 7, 2004·European Journal of Pharmacology·István NagyLászló Urbán
Dec 8, 2004·Current Drug Targets. CNS and Neurological Disorders·Mitsuko Numazaki, Makoto Tominaga
Dec 17, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Paulo DinisFrancisco Cruz
Mar 15, 2005·Neuroscience Letters·Tohko IidaMichael Caterina
Apr 28, 2005·Clinical and Experimental Pharmacology & Physiology·Douglas G Whyte, Alan Kim Johnson
May 3, 2005·Brain Research·Urban KarlssonJohannes J Krupp
Aug 19, 2005·The EMBO Journal·Mario van der SteltVincenzo Di Marzo
Apr 20, 2006·Bioorganic & Medicinal Chemistry·Irene DrizinChih-Hung Lee
Sep 15, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·M CuiC R Faltynek
Jan 2, 2007·Seminars in Cell & Developmental Biology·David C Immke, Narender R Gavva
Feb 27, 2007·Biochimica Et Biophysica Acta·Jon D Levine, Nicole Alessandri-Haber
Mar 30, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Narender R GavvaJean-Claude Louis
Apr 28, 2007·Nature Reviews. Drug Discovery·Arpad SzallasiSamer R Eid
Jul 13, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Alexandre A SteinerAndrej A Romanovsky
Jul 27, 2007·The Journal of Pharmacology and Experimental Therapeutics·Narender R GavvaJames J S Treanor

❮ Previous
Next ❯

Citations

Jul 24, 2012·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Dong Dong ZhangKlaus Scholich
Sep 15, 2009·Pharmacological Reviews·Andrej A RomanovskyTatiane B Nucci
Mar 2, 2012·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Cheryl H Vaughan, Timothy J Bartness
Feb 4, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andras GaramiAndrej A Romanovsky
Dec 3, 2013·Physiology & Behavior·Zita PetrovszkiGyöngyi Horvath
Nov 10, 2009·Pharmacology & Therapeutics·Khadija Alawi, Julie Keeble
Dec 23, 2008·Trends in Molecular Medicine·Neelima Khairatkar-Joshi, Arpad Szallasi
Dec 10, 2008·Drug Discovery Today·Martin J Gunthorpe, Boris A Chizh
Nov 11, 2008·Pulmonary Pharmacology & Therapeutics·Masaya TakemuraDavid A Groneberg
Sep 13, 2019·International Journal of Molecular Sciences·Chia-Ming YenYi-Wen Lin
Apr 9, 2021·Biochemistry. Biokhimii︠a︡·Irina N GladkikhSergey A Kozlov

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.